Weed (BUDZ) Change in Cash (2010 - 2026)
Weed's (BUDZ) quarterly Change in Cash came in at -$28537.0 in Q1 2026, up 81.72% year-on-year from -$15703.6 in Q1 2025, and down 187.17% quarter-over-quarter from $32737.0 in Q4 2025.
Weed (BUDZ) Change in Cash (2010 - 2026) Analysis & Trends
Weed's Change in Cash history runs 13 years deep, the most recent figure standing at -$28537.0 for Q1 2026.
- On a quarterly basis, Change in Cash rose 81.72% year-over-year to -$28537.0 in Q1 2026; TTM through Mar 2026 was $2567.0, a 102.6% increase from a year earlier, with the FY2025 full-year figure at -$125034.0, up 4.01% from the prior year.
- Change in Cash slipped to -$28537.0 in Q1 2026 per BUDZ's latest filing, from $32737.0 in the prior quarter.
- Across five years, Change in Cash topped out at $784897.0 in Q2 2022 and bottomed at -$354885.0 in Q4 2023.
- The 5-year median for Change in Cash is -$28537.0 (2026), against an average of -$1142.6.
- Across the five-year window, Change in Cash soared 15173.88% in 2022 and slumped 1567.39% in 2023, its largest moves.
- Year by year, Change in Cash stood at -$220249.0 in 2022, then slumped by 61.13% to -$354885.0 in 2023, then jumped by 143.37% to $153899.0 in 2024, then tumbled by 78.73% to $32737.0 in 2025, then plunged by 187.17% to -$28537.0 in 2026.
- Per Business Quant, the three latest BUDZ Change in Cash figures stand at -$28537.0 (Q1 2026), $32737.0 (Q4 2025), and -$4952.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -117.00 Mn |
| 10 | Weed | 3.72 Mn | 3.72 Mn | - | -28,537.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28,537.00 |
| Dec 31, 2025 | 32,737.00 |
| Sep 30, 2025 | -4,952.00 |
| Jun 30, 2025 | 3,319.00 |
| Mar 31, 2025 | -156,138.00 |
| Dec 31, 2024 | 153,899.00 |
| Sep 30, 2024 | -9,703.00 |
| Jun 30, 2024 | -86,721.00 |
| Mar 31, 2024 | -187,730.00 |
| Dec 31, 2023 | -354,885.00 |
| Sep 30, 2023 | 609,869.00 |
| Jun 30, 2023 | -66,015.00 |
| Mar 31, 2023 | -219,962.00 |
| Dec 31, 2022 | -220,249.00 |
| Sep 30, 2022 | -284,243.00 |
| Jun 30, 2022 | 784,897.00 |
| Mar 31, 2022 | 14,990.00 |
| Dec 31, 2021 | 17,961.00 |
| Sep 30, 2021 | -35,951.00 |
| Jun 30, 2021 | -5,207.00 |